Resource icon

Resource Amitriptyline Gets Mixed Report on Neuropathic Pain

Cort

Founder of Health Rising and Phoenix Rising
Staff member
Cort submitted a new resource:

Amitriptyline Gets Mixed Report on Neuropathic Pain - The most common drug for neuropathic pain gets mixed review

This Cochrane Report highlights how far we have to go in treating neuropathic pain. A tricyclic antidepressant, Amitriptyline line is one of the most commonly used drugs to treatment neuropathic pain (tingling, burning, etc. sensations).

After analyzying fifteen authors concluded that there wasn't much good evidence that Amitriptyline was all that helpful. Many of the studies were small and poorly done. They acknowledged that the drug does help people - just not that many. (It's...
Read more about this resource...
 
Thanks Cort. It was next on my list to try, but I am also nervous of its side-effects, having seen first hand the profound negative impact it had on my father - his urinary system pretty much ground to a halt. If there's no good evidence for it, maybe I'll give it a miss.
 

Get Our Free ME/CFS and FM Blog!



Forum Tips

Support Our Work

DO IT MONTHLY

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Shopping on Amazon.com For HR

Latest Resources

Top